Blood Res.  2017 Sep;52(3):218-219. 10.5045/br.2017.52.3.218.

Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?

• Niscola P
• Caravita T
• Tatangelo
• Siniscalchi A
• de Fabritiis P
• Palumbo R

• KMID: 2390985
• DOI: http://doi.org/10.5045/br.2017.52.3.218

Abstract

No abstract available.

Reference

1. Niscola P, Vischini G, Tendas A, et al. Management of hematological malignancies in patients affected by renal failure. Expert Rev Anticancer Ther. 2011; 11:415–432. PMID: 21417855.

2. Niscola P, Tendas A, Luo XD, et al. The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature. Cardiovasc Hematol Agents Med Chem. 2013; 11:67–76. PMID: 23016546.

3. Launay-Vacher V, Oudard S, Janus N, et al. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer. 2007; 110:1376–1384. PMID: 17634949.

4. Hong J, Lee S, Chun G, et al. Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma. Blood Res. 2016; 51:113–121. PMID: 27382556.

5. Terpos E, Christoulas D, Kastritis E, et al. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPICysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations? Eur J Haematol. 2013; 91:347–355. PMID: 23829647.

6. Ofran Y, Tallman MS, Rowe JM. How I treat acute myeloid leukemia presenting with preexisting comorbidities. Blood. 2016; 128:488–496. PMID: 27235136.

7. Niscola P, Scaramucci L, Vischini G, et al. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010; 11:752–758. PMID: 20041843.

8. Malik L, Mejia A, Weitman S. Eligibility of patients with renal impairment for Phase I trials: Time for a rethink? Eur J Cancer. 2014; 50:2893–2896. PMID: 25241228.

9. Salahudeen AK, Bonventre JV. Onconephrology: the latest frontier in the war against kidney disease. J Am Soc Nephrol. 2013; 24:26–30. PMID: 23138480.